``Eight pharmaceutical companies, including the nation's three largest, doled out more than $220 million last year to promotional speakers for their products, according to a ProPublica analysis of company data.
For the first time, all these companies have reported a full year of payments, allowing for head-to-head comparisons of how much they spent on physicians to help push their pills.´´
| Company | 2010 Speaker Payments | 2010 U.S. Sales |
|---|---|---|
| Lilly | $61,477,547 | $14.3 billion |
| GlaxoSmithKline | $52,755,793 | $13.6 billion |
| Pfizer | $34,382,574 | $26.2 billion |
| AstraZeneca | $31,647,101 | $18.3 billion |
| Merck | $20,365,446 | $18.8 billion |
| Johnson & Johnson | $11,712,900 | $12.9 billion |
| Cephalon | $4,241,080 | $2.1 billion |
| ViiV Healthcare | $3,975,102 | Unavailable |
(Regular Medical Education is required to renew the medical license, Doctors need to attend seminars and take courses. However, in hundreds of hours of Medical Education I have attended, the speakers have not promoted any one drug in particular. Doctors pay to receive the medical education credits. MJ)
No comments:
Post a Comment